| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
United Therapeutics Corporation (UTHR) has 16 insiders with recent SEC Form 4 filings, including 0 buys and 69 sells. UTHR is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | Rothblatt Martine A | 66.0K | $35.53M | - |
| VP | Mahon Paul A | 44.5K | $23.95M | - |
| CEO | 40.5K | $21.81M | -28,500 | |
| VP | 33.5K | $18.03M | - | |
| CFO | Edgemond James | 19.9K | $10.71M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | Thompson Tommy G51 | Director | Sale+OE | 2,500 | $318.34 | $795,837.75 | -22.8% | +0.1% | +57.4% | |
| Feb 24, 2025 | Benkowitz Michael47 | President And COO | Sale+OE | 10,000 | $360.76 | $3,607,554.55 | -34.8% | -12.1% | +32.1% | |
| Feb 18, 2025 | Benkowitz Michael47 | President And COO | Sale+OE | 10,000 | $371.05 | $3,710,499.18 | -23.7% | -18.1% | +27.7% | |
| Feb 10, 2025 | Benkowitz Michael47 | President And COO | Sale+OE | 10,000 | $348.06 | $3,480,642.28 | -34.9% | -10.1% | +36.9% | |
| Feb 3, 2025 | Benkowitz Michael47 | President And COO | Sale+OE | 10,000 | $353.64 | $3,536,397.68 | -16.7% | -15.8% | +34.9% | |
| Jan 27, 2025 | Benkowitz Michael47 | President And COO | Sale+OE | 10,000 | $370.71 | $3,707,080.71 | -49.0% | -19.6% | +29.0% | |
| Jan 21, 2025 | Benkowitz Michael47 | President And COO | Sale+OE | 4,900 | $365.71 | $1,791,999.49 | -48.5% | -22.8% | +27.7% |